Mostrando entradas con la etiqueta vaccine. Mostrar todas las entradas
Mostrando entradas con la etiqueta vaccine. Mostrar todas las entradas

As demand for COVID-19 vaccines collapses in many areas of the U.S., states are scrambling to use stockpiles of doses before they expire and have to be added to the millions that have already gone to waste.

From some of the least vaccinated states, like Indiana and North Dakota, to some of the most vaccinated states, like New Jersey and Vermont, public health departments are shuffling doses around in the hopes of finding providers that can use them.

State health departments told The Associated Press they have tracked millions of doses that went to waste, including ones that expired, were in a multi-dose vial that couldn’t be used completely or had to be tossed for some other reason like temperature issues or broken vials.

Nearly 1.5 million doses in Michigan, 1.45 million in North Carolina, 1 million in Illinois and almost 725,000 doses in Washington couldn’t be used.

The percentage of wasted doses in California is only about 1.8%, but in a state that has received 84 million doses and administered more than 71 million of them, that equates to roughly 1.4 million doses. Providers there are asked to keep doses until they expire, then properly dispose of them, the California Department of Public Health said.

The national rate of wasted doses is about 9.5% of the more than 687 million doses that have been delivered as of late February, the Centers for Disease Control and Prevention said Thursday. That equates to about 65 million doses.

The problem is not unique to the U.S. More than a million doses of the Russian Sputnik vaccine expired this week in Guatemala, because nobody wanted to take the shot.

Vaccination program managers say that tossing out doses is inevitable in any inoculation campaign because of the difficulty in aligning supply and demand for a product with a limited shelf life.

But the coronavirus pandemic has killed nearly 6 million people and shattered economies across the globe, and every dose that goes to waste feels like a missed opportunity considering how successful the vaccines are in preventing death and serious disease.

It also comes only about a year after people desperate to get the vaccine attempted to jump in line to get ahead of those deemed higher priority. Hospital board members, their trustees and donors around the U.S. got early access or offers for vaccinations, raising complaints about favoritism and inequity at a time when the developing world had virtually no doses.

And many poorer nations still have low vaccine rates, including 13 countries in Africa with less than 5% of their population fully vaccinated. T hey are plagued by unpredictable deliveries, weak health care systems, vaccine hesitancy and some supply issues, although health officials say inventory is markedly stronger than earlier in the pandemic.

In fact, supplies are so strong that the CDC now advises doctors that it’s OK to discard doses if it means opening up the standard multi-dose vials to vaccinate a single person and the rest has to be tossed.

“Pivoting to what’s happening now, you have much more production and distribution to low-income countries,” said Dr. Joseph Bresee, who directs the COVID-19 Vaccine Implementation Program at the Task Force for Global Health in Decatur, Georgia. “The issue of some stockpiles in the U.S., Germany and Japan, that are not redistributed to sub-Saharan Africa, it’s less of an acute problem now because vaccine production and distribution is in high-gear right now serving those low-income countries.”

The Department of Health and Human Services also said that redistributing states’ excess doses to other nations is not feasible because of the difficulty in transporting the shots, which must remain cold, in addition to not being cost effective because of the relatively small number concentrated at sites.

Of the more than 687 million doses sent to states, 550 million to 600 million have been administered, HHS said Monday. The vaccines authorized in the U.S., made by Pfizer, Moderna and Johnson & Johnson, can last for up to about six months from the time of manufacture.

A senior HHS official familiar with vaccine distribution plans took issue with the word “wastage,” saying it implies mismanagement when states are effectively overseeing their inventories. The CDC, however, uses the term “wastage” on its website and asks states to report their numbers.

The CDC said Thursday that the federal government, jurisdictions and vaccine providers have a strong partnership to get as many people vaccinated as possible while reducing vaccine wastage, and that the likelihood of leaving unused doses in a vial may increase as demand slows, even when providers continue to follow best practices to use every dose possible.

The fading demand comes as the pandemic itself wanes in the U.S. On Thursday, the CDC said about 90% of the U.S. population lives in counties where the risk of coronavirus is posing a low or medium threat — meaning residents don’t need to wear masks in most indoor settings. That was up from 70% last week.

FILE - Prepared Pfizer COVID-19 vaccine syringes wait for patients at a middle school in Wheeling, Ill., June 11, 2021.

FILE – Prepared Pfizer COVID-19 vaccine syringes wait for patients at a middle school in Wheeling, Ill., June 11, 2021.

The average number of Americans getting their first shot is down to about 70,000 a day, the lowest point since the U.S. vaccination campaign began in December 2020. About 76% of the U.S. population has received at least one shot and roughly 65% of all Americans are fully vaccinated.

With demand so low, states will undoubtedly be confronted with more waste in the months ahead, although they will benefit from any booster expansions.

Idaho, for example, has 230,000 doses on hand but is only averaging fewer than 2,000 doses administered a week.

Oregon’s vaccination rate is slightly higher than the national average, but the health authority there said last week that they have “significant excess vaccine on hand” because of the recent drop in demand. The state is trying to use up as many of the 716,000 doses in its inventory as possible.

Rhode Island has the highest percentage of residents who are fully vaccinated in the nation, at slightly more than 80%, but the health department reported having 137,000 doses on hand last week. Health officials say they need them for a big push to increase the vaccination rate for booster doses.

Health officials in some states have developed “matchmaker” programs to connect vaccine providers with excess doses with providers seeking doses. Many said they’re attempting to redistribute doses with expiration dates that are quickly approaching. New Jersey has a task force that has transferred more than 600,000 doses around the state since June. West Virginia has offered to transfer Pfizer adult doses to nearby states.

Immunization managers have been asking for single-dose vials, especially for pediatricians, but it may not work for manufacturers to package it that way yet, said Claire Hannan, executive director at the Association of Immunization Managers. She said wasting vaccine “just can’t be an issue.”

“We tell this to providers, but the most important thing is getting people vaccinated. And that’s hard when the demand goes down. You don’t have constant flow,” she said. “But that’s just a necessary evil I guess.”

HHS said states are ordering prudently, paralleling the drop in demand. The minimum order for Pfizer used to be nearly 1,200 doses but now it’s 100, and Moderna reduced the number of doses per vial, the agency said.

“Given what we’ve seen in terms of the number of people still unvaccinated, I do think finding any way to get the shot in arms, even at the expense of potential wastage, is still important,” said Katie Greene, an assistant research director at the Duke-Margolis Center for Health Policy.

With the global vaccine supply exceeding distribution capacity, the Biden administration is acknowledging a need to adjust its pandemic response strategy to address hurdles faced by lower-income countries to vaccinate their citizens.

“It is clear that supply is outstripping demand and the area of focus really needs to be that ‘shots in arms’ work,” said Hilary Marston, White House senior policy adviser for global COVID, to VOA. “That’s something that we are laser-focused on for 2022.”

Marston said that the administration has helped boost global vaccine supply through donations, expanding global manufacturing capacity and support for COVAX, the international vaccine-sharing mechanism supported by the United Nations and health organizations Gavi and CEPI.

Following supply setbacks in 2021, COVAX’s supply is no longer a limiting factor, a Gavi spokesperson told VOA. He said COVAX now has the flexibility to “focus on supporting the nuances of countries’ strategies, capacity, and demand.”

However, the pivot from boosting vaccine supply to increasing delivery capacity depends on whether the administration can secure funding from Congress, including funds for the U.S. government’s Initiative for Global Vaccine Access, or Global VAX, a program launched in December by USAID, the U.S. Agency for International Development.

Global VAX is billed as a whole-of-government effort to turn vaccines in vials into vaccinations in arms around the world. It includes bolstering cold chain supply and logistics, service delivery, vaccine confidence and demand, human resources, data and analytics, local planning, and vaccine safety and effectiveness.

Four-hundred-million dollars from the American Rescue Plan Act has been put aside for this initiative, on top of the $1.3 billion for global vaccine readiness the administration has committed. Activists say this is not nearly enough, but USAID says it’s a good first step.

“The U.S. government will surge support for an initial subset of countries in sub-Saharan Africa that have demonstrated the potential for rapid acceleration of vaccine uptake with intensive financial, technical, and diplomatic support,” a USAID spokesperson told VOA.

Those countries include Angola, Côte d’Ivoire, Eswatini, Ghana, Lesotho, Nigeria, Senegal, South Africa, Tanzania, Uganda, and Zambia.

FILE - A worker handles the cargo of COVID-19 vaccines, donated through the U.N.-backed COVAX program in Madagascar, May 8, 2021.

FILE – A worker handles the cargo of COVID-19 vaccines, donated through the U.N.-backed COVAX program in Madagascar, May 8, 2021.

Critical bottleneck

In January, COVAX had 436 million doses of COVID-19 vaccines to allocate to lower-income countries, according to a document published in mid-February. Those countries, however, only asked for 100 million doses to be distributed by the end of May – the first time in 14 allocation rounds that supply has outstripped demand, the document from the COVAX Independent Allocation of Vaccines Group said.

“We’ve seen now 11 billion plus doses of vaccine being manufactured,” said Krishna Udayakumar to VOA. “We’re estimating 14- to 16- plus billion doses of vaccine being available in 2022,” added Udayakumar, who is founding director of the Duke Global Health Innovation Center and leads a team that tracks global vaccine production and distribution.

But rather than fulfilment of vaccination targets, the oversupply highlights a weakness in global distribution capacity, which Udayakumar said is becoming “the critical bottlenecks.”

Only 12% percent of people in low-income countries have received at least one dose, according to country data compiled by Our World in Data. Many countries still face massive hurdles to get those shots in arms, including gaps in cold-chain storage, and lack of funding to support distribution networks.

Global COVID funding

As the administration prepares to pivot its global pandemic response, humanitarian organizations are criticizing it for requesting insufficient funding from Congress.

“After two devastating years of this pandemic, U.S. leaders are dropping the ball on fighting COVID-19. Today we learned the Biden administration briefed Congress on the need for $5 billion in funding from Congress to fight COVID-19,” said Tom Hart, president of the ONE Campaign, in a statement to VOA last week. “What the world needs, though, is a formal request for $17 billion.”

Hart argued the $5 billion funding would be insufficient to provide critical resources needed to deliver vaccines, tests, and life-saving treatments to low-income countries, and achieve the administration’s goal of 70% global vaccination by September – a goal that is already far below pace.

The White House said the number is not final. “I don’t have any specific numbers; we’re still in conversation with the Hill (Congress) at this point about funding and funding needs, both domestically and internationally,” press secretary Jen Psaki told VOA on Wednesday.

In a statement to VOA, the chair of the House Appropriations Committee, Rosa DeLauro, said they are still reviewing the funding request. “I will work with my colleagues to meet these important public health needs at home and around the world,” she said.

Meanwhile, Gavi, a COVAX co-sponsor, said it has only raised $195 million out of the $5.2 billion it asked for this quarter. The Gavi spokesperson told VOA the call to donors only went out in January and typically campaigns such as this require extensive rounds of consultation.

“The reason we launched a campaign to raise US $5.2 billion in additional funding is to ensure countries are able to roll out vaccines rapidly and at scale and have the resources on hand to be able to immediately step in as and when countries’ needs change,” the spokesperson said. “We need resources available now to prevent lower income countries once again finding themselves at the back of the queue. This is the only way we will break this pandemic.”­

TRIPS waiver

Humanitarian organization Oxfam also argues that $5 billion dollars is not enough.

“We need to do much more to vaccinate the world, including investing in local manufacturing and most importantly, sharing the vaccine recipe,” Robbie Silverman, Oxfam’s senior advocacy manager told VOA.

Sharing vaccine recipes essentially means implementing a temporary TRIPS (Trade-Related Aspects of Intellectual Property Rights) waiver at the World Trade Organization to allow the generic production of current vaccines, as proposed by South Africa and India in October 2021. The proposal is supported by the Biden administration but rejected by the European Union.

Following a summit between European Union and African Union leaders last week, European Commission President Ursula von der Leyen offered a compromise and said that the EU and AU will work together to deliver a solution within the next few months.

The U.S. is by far the biggest vaccine donor. The administration is sending 3 million doses of COVID-19 vaccines to Angola, Sierra Leone, Rwanda, Zambia and Uganda this week, bringing the total shipped globally to 470 million doses out of 1.2 billion doses pledged.

Hong Kong rolled out vaccine passports on Thursday requiring people aged 12 and above to have at least one COVID-19 jab, and paved the way for mainland China manpower to help bring a worsening outbreak under control.

Residents will have to show their vaccine record to access venues including supermarkets, shopping malls and restaurants, a major inconvenience in a city where malls link train stations to residences and office buildings.

Separately, city leader Carrie Lam used emergency powers granted under British colonial-era laws to exempt mainland Chinese staff and projects from any licensing or other legal requirements to operate in Hong Kong.

City authorities have asked their mainland Chinese counterparts for help to build additional isolation, treatment and testing facilities, and boost the workforce as Hong Kong’s health system is increasingly overwhelmed.

“Hong Kong’s healthcare system, manpower, anti-epidemic facilities and resources … will soon be insufficient to handle the huge number of newly confirmed cases detected every day,” the government said in a statement.

On Wednesday, Hong Kong reported a record 8,674 new COVID-19 infections as the global financial hub prepares for compulsory testing of its 7.4 million people – part of its “dynamic zero COVID” strategy similar to mainland China.

Allowing mainland doctors to practice in Hong Kong has been a controversial issue in the global financial hub, which for decades had some of the toughest licensing standards as a way to preserve excellence in its public health system.

The city last year passed a law allowing overseas-trained doctors to practice without taking a local licensing exam, in a move contested by many local doctors.

Hong Kong’s medical front lines have been weakened sharply by the latest outbreak, with some 1,200 medical staff infected as of Wednesday.

Authorities also tightened restrictions from Thursday in a city that already has some of the most stringent rules in the world. Residents will have to wear masks for all outdoor exercise and will not be allowed to remove them to eat or drink on public transport.

With bars, gyms and other businesses already closed and shopping malls deserted while many residents work from home, the government said on Tuesday schools would break early for summer and resume the new year in August.

Many in the city are growing fatigued with the situation, as most other major cities learn to live with the virus.

As the urgency grows, construction work has started on a facility on Lantau Island to build about 10,000 isolation units, while private hospitals will take in patients from public hospitals.

With the city’s testing, treatment and isolation capacity already stretched to the maximum, University of Hong Kong researchers predicted new infections could peak at 180,000 a day next month.

The newborn baby, safe from the coronavirus… even more so with the mother’s vaccines

“It is also important to underline that the few infections from the mother to the baby, whether during pregnancy or childbirth, 15 cases of the 2,874 tested, have been diagnosed as a mild covid infection and have always evolved positively and without complications. », rounds up the also head of the Neonatology Service of the Gregorio Marañón University General Hospital in Madrid.

“And for greater health satisfaction, the vaccines against this virus and its different mutations, now with omicron on the crest of the wave, have meant a before and after when pregnant women with coronavirus develop respiratory failure: we have gone from clinical symptoms severe to mild clinical pictures”, highlights the doctor from Madrid.

“As if that were not enough, it should be added that of the 162 cases of postnatal infection, after childbirth, both in the hospital setting and in the family home, only 8% of the babies had symptoms for which their admission to care was advisable. intensive due to suffering, most of them, previous risk factors, such as heart disease and prematurity”.

Exterior facade of the maternal and child hospital of the Hospital General Universitario Gregorio Marañón in Madrid.
seNeo recommends vaccination and extreme prevention measures against coronavirus in all cases. Pregnant women should not live in a bubble, but should systematically avoid pandemic infection vectors

Data and keys of the seNeo covid registry on the newborn

The registry of covid cases of the Spanish Society of Neonatology is created to know the impact of SARS-Cov-2 infection in newborns; a set of “own data” compiled both from infected mothers and their newborns -perinatal situation- and from those other babies who were infected in the postnatal period.

135 Spanish public and private hospitals collaborate meticulously in the project.

The main objective of this seNeo registry is to compute all the clinical statistics on pregnancies and births during the pandemic in order to prepare a series of recommendations based on scientific evidence.

«This exhaustive database, fed by hundreds of professionals, who work very hard, coordinated by the seNeo infectious diseases group, with the Dr. Belen Fernandez Colomer of the Central Hospital of Asturias at the helm, improves our strategy against a disease unknown at the beginning of 2020 and unheard of to date»

Dr. Manuel Sánchez Luna, president of the Spanish Society of Neonatology

Dr. Manuel Sánchez Luna, head of the Neonatology Service at the Hospital General Universitario Gregorio Marañón in Madrid and president of the Spanish Society of Neonatology (seNeo).

4,737 perinatal cases of covid mothers

Since the cases began to be assessed during the first wave of COVID-19, the profile of pregnant women indicates that they have a mean age of 32 years and 73% of them were previously healthy, despite showing a high prevalence of obesity.

In 80% of the 4,737 cases analyzed, the pregnant women did not suffer from gestational pathologies; being the preeclampsia the most frequent complication in this group of women.

“Mothers who were admitted to the ICU for covid developed the disease in the third trimester, probably due to greater respiratory compromise. More cases of obesity and preeclampsia were described in this group of patients”, Dr. Sánchez Luna reiterates.

“We must bear in mind – he explains – that severe forms of covid are more common among pregnant women than in non-pregnant women. Still, 50% of recorded infections were asymptomatic.”

Throughout the period studied, the cesarean section rate has stood at 23% nationwide, a lower percentage than the pre-pandemic rate, which was 25% in 2019.

“It is likely that virus mutations have something to do with these data, but also, very likely, vaccination, since this preventive measure has modified the severity profile, with the need for admission to the ICU now being very infrequent. of vaccinated pregnant women”, testifies.

Late fetal death -from the 28th week of gestation, according to the WHO- has been very low: 2.8 per thousand pregnancies, also lower than the pre-pandemic rate.

The overall rate of prematurityfortunately, has been declining throughout the pandemic.

“At the beginning it was very high, 26.5%, but currently it is less than 5% and it is late prematurity (34 to 37 weeks), usually due to the need to improve the respiratory situation of the mother in the most severe cases” , highlights.

“We are pleased to say that the 94.5% of newborns have done rooming-in with his mother, without complications, avoiding the separation of both. When this mother-baby union has not been possible, it has been due to covid symptoms that forced us to separate them; that yes, the minimum possible time».

Dr. Manuel Sanchez Luna

“It is interesting to see -he points out- how the children of covid mothers behave at birth in the same way as the children of non-covid mothers,” he mentions.

Skin-to-skin contact was carried out in 78% of the deliveries and the delayed clamping of the umbilical cord in 68% of cases.

When the presence of antibodies in the mother has been determined, these have been detected in 85% of her babies. In 2.2% of those born without symptoms, the PCR was positive. In boys and girls with symptoms, the positivity in PCR was similar to the asymptomatic ones.

Of the 2,874 tested, only in 15 cases the PCR was persistently positive. The final rate of infection was 1% in newborns..

‘It is very interesting to see how the infection rate in the babies who were not separated from their mothers turned out to be lower than that in the group of babies who had to be separated from their mothers; and in addition, in those who continued breastfeeding the rate was lower than those who received donated milk from other mothers»

Dr. Manuel Sanchez Luna

On the whole, the breastfeeding rate was 88%one more success of the recommendations of the Spanish Society of Neonatology.

162 postnatal cases, covid infections after childbirth

From 54 hospitals, 162 cases of babies with postnatal infection have been reported, either in the health field or in the family home. There is a decrease in the number of cases in recent months. Symptoms have generally been mild; some did not require admission.

8% were admitted to the neonatal ICU, most with previous risk factors such as prematurity or heart disease. The most frequent symptom was fever, irritability and rhinorrhea -runny nose-.

In addition, they showed little analytical alteration and the radiological tests showed only some cases of non-specific infiltration -viral pneumonia-«.

“Most postnatal infections have occurred in the family home and very few have been infected in the hospital by their parents or by health personnel, most of them, moreover, in the first wave.

These cases of neonatal infection, in general, have been mild and with a good prognosis, without added problems in the medium and long term.

“In summary, in both cases, perinatal and postnatal infection, we can say that these newborn babies have formed a low-risk group because their mothers have most likely protected them either through the placenta or through breastfeeding.”

“In this same sense, many of these babies have received antibodies against the coronavirus generated by the maternal vaccine. One of the reasons why the Spanish Society of Neonatology strictly recommends the vaccination of pregnant women. Vaccination protects mothers from SARS-CoV-2 in its most serious forms»

Dr. Manuel Sanchez Luna

Likewise, seNeo advises that the management of newborns of covid mothers, always taking extreme hygiene and safety measures, must be practically the same as the cases of babies of mothers without infection.

“It is essential to maintain the joint hospital stay, skin-to-skin contact and encourage breastfeeding. They are safe strategies for mothers and their babies«, Dr. Manuel Sánchez Luna concludes the interview.

In a symbolic act with the presence of President Iván Duque, putting together the pieces of a puzzle was the way to start the construction works of the plant to manufacture vaccines in Colombiain a lot of 35,000 square meters, in the municipality of Rionegro, east of Antioch.

Although this was the formal beginning, the walls will not begin to rise until the Urban Curator approves the license that has already been filed, after the Mayor’s Office of Planning gave the endorsement that determines the use of the land.

For now, Vaxtheraa Grupo Sura company, reported that the design of the plant complies with national and international regulations on good manufacturing practices (GMP).

The construction of the plant will be carried out in two stages. The first will have 10,000 square meters, which will house the so-called fill and finish, potency and toxicity laboratories, storage centers and service buildings. In the second stage, production units, the administrative block and the research unit will be integrated.

fill and finish This means that the company, initially, will do what is known in the industry as the filling and completion of the biological packaging process, for which a capacity of 100 million doses per year and the generation of between 500 and 1,000 jobs.

(We recommend you read: Is there no longer an omicron in Medellín?)

It means then that, in this first part, projected for mid-2023, the country will not yet produce its own vaccinesbut different agreements will be negotiated with the National Government and international alliances to strengthen biotechnological capacity and knowledge transfer.

Vaccine plant in Colombia

Colombia begins the construction of the first vaccine plant. Vaxthera, of the Sura group, which will have a production capacity in its initial phase of 100 million vaccines.

Photo:

Jaiver Nieto Alvarez / ETCE

Jorge Emilio Osorio, president of Vaxthera, indicated that there are already agreements with the company Providence, from Canada, and the Serum Institute, from India, among other companies in the world, for technology transfer of different vaccine productions, taking into account that biologicals will not only be developed to combat covid-19, but also dengue, chikungunya, yellow fever, influenza and zika.

“We are going to have finished the unit of fill and finish in 2023, then comes a licensing process, appraisal by Invimathat we have all the production standards, and by the end of 2023 we will be making vaccines in Colombia,” Osorio said.

The plant is part of the Ministry of Health’s 10-year plan, which is divided into three stages: the first is training in filling vaccines, the second is local production, and the third is research and development to generate vaccines.
Vaxthera stressed that this company is developing a vcradle against the coronavirus called Univax, which is designed to combat the different variants of covid-19 and has already shown favorable results in preclinical studies. It has been tested, for example, in the delta variant, but it remains to be done in the omicron.

“This will be an excellent booster vaccine and we hope to be in phase 1 and 2 clinical studies after the second half of the year,” Osorio said.

(Also read: They would suspend payment for circulating in peak and plate if air quality worsens)

Why a plant?

Fernando Ruiz, Minister of Health, pointed out that the fundamental thing is to recover the sanitary sovereignty that the country lost 22 years agowhen the National Institute of Health laboratory that produced its own vaccines was closed.

The investment in this project was 54 million dollars, and the objective is to face the different existing health emergencies and to be prepared for emerging diseases.

Precisely, for the expert Diego Rojas Vahos, director of the Center for Pharmaceutical Science and Research (Cecif) of the CES University, this aspect was the one that evidenced the covid-19 pandemic: Colombia depends to a high extent on imports, not only of vaccines, but of masks and medical supplies.

(Also read: ‘My hair was burned, I recovered and created a hair products company’)

As President Iván Duque mentioned, at the time the decision was made to stop producing vaccines because it was cheaper to buy them abroad.

We felt that pain of having to negotiate, having so many complexities that not only Colombia suffered, but the world, in a country that has stopped producing vaccines

“Yes, it is cheaper, but it does not give us pharmaceutical sovereignty or independence for a crisis like the pandemic, which can be repeated, for example, in an environmental catastrophe, or in border closures that can occur due to economic blockades. In a war, with two or three neighboring countries, we would also have closed borders and we would need to supply necessities”, explained Rojas.

The Ministry of Health pointed out that one of the most complex issues is negotiating vaccines with other countrieswhich began in the second half of 2020, when the National Government was managing the necessary vaccines for Colombia, which at this time are almost 97 million vaccines insured.

“We felt that pain of having to negotiate, having so many complexities that not only Colombia suffered, but the world, in a country that has stopped producing vaccines. In January we started this National Vaccine Production Plan in the ministry, which we presented to the council of ministers and from which we obtained its approval. It is an ambitious plan: to go from having a country without sovereignty to a country with sovereignty in the production of vaccines (…). We depend on the Covax system, which is where it is left over, it is not given away. It is collected by the World Health Organization and distributed to the countries”, explained Minister Ruiz.

MELISSA ALVAREZ CORREA
Editor of EL TIEMPO – Medellín
On Twitter: @Melissalvarez3

More employment and the consolidation of a science and technology hub are part of the implications for Antioquia the beginning of the construction of a plant in the municipality of Rionegro, that will make Colombia return to its own production of vaccines, after more than 20 years.

The first stone was symbolically laid this Wednesday by President Iván Duque and other regional and national authorities, completing a puzzle with the logo of VaxThera, the Sura Group company that will carry out this project.

(You may be interested: This is the official date given by EPM for the startup of Hidroituango)

Although that was the way to start the construction of the plant, a permit is pending to start building the infrastructure, which in its first phase includes 10,000 square meters, in a lot of more than 35,000.

Jorge Emilio Osorio, president of VaxThera explained that this first phase will last until June 2023 and it is estimated that 100 million doses of vaccines will be produced per year.

We have already filed all the documents in the Mayor’s Office of Rionegro to start construction. We are simply waiting for approval so we can start immediately

“We have already filed all the documents with the Rionegro mayor’s office to start construction. We are simply waiting for approval to start immediately,” said Osorio.

After that phase, in the next phase it is estimated that there will be a production of between 200 and 250 million doses per year, which will generate between 500 and 1,000 jobs annually in this municipality in Eastern Antioquia.

(We recommend: Gustavo Petro’s strategy to conquer Antioquia)

“Rionegro celebrates it for the opportunity it has in terms of job creation, but also because this is the gateway to that technological hub of scientific development, innovation and creativity that we can have in our territory,” said Rodrigo Hernández Alzate , mayor of Rionegro.

The president indicated that the Rionegro Council approved tax relief for industry and commerce and property tax so that this Sura group company could have incentives and make the decision to build the plant in this municipality in the East and not in Valle del Cauca. or Cundinamarca, which were other options.

“That tax incentive that we gave precisely seeks to encourage the generation of employment, of those jobs a large majority are with people from here in Rionegro. We have to continue advancing in the training of more professionals from this territory, from the entire department,” he explained. Hernandez.

(Also read: Beware of this modality of scam using vacancies from the U. de Antioquia)

The construction license was filed with the Rionegro Urban Curator, so a prompt approval response is expected. In turn, the Planning Office of said municipality evaluated this request, taking into account the Land Use Plan and determined that it was consistent with the use of the land.

The airport

For Aníbal Gaviria, governor of Antioquia, having this plant in the department also means giving continuity to projects in Rionegro, where the José María Córdova international airport is located.

What is going to be done is to consolidate that hub and many other industries with high added value, and that requires the expansion of the José María Córdova airport and the second runway there.

“What is happening here is the seed for the beginning of a hub for science, technology, health, a hub for life. Let us remember that here we already have the San Vicente Hospital and that what is going to be done is to consolidate that hub and many other industries with high added value and that requires the expansion of the José María Córdova airport and the second runway there,” explained the president.

Gaviria mentioned that one of the most important aspects is the alliance between the University of Wisconsin, the National University and the Sura Group.with the support of local and national governments, to train more professionals in the scientific aspect.

(Be sure to read: They frustrate the alleged robbery of congressmen from the Democratic Center in Medellín)

For now, The company Vaxthera is developing a vaccine against covid-19 called UNIVAXwhich is designed to combat the different variants of the SARS-CoV-2 virus and has shown positive results in preclinical studies.

“This will be an excellent booster vaccine and we hope to be in phase 1 and 2 clinical studies after the second half of the year.”Osorio said.

Once it is approved for use in humans, this would be a positive aspect so that there is no shortage of vaccines in Antioquia, just as it has occurred in other departments of the country.

“Not only are they going to produce vaccines for covid, but also vaccines for the Immunized Vaccination Plan, which is also very important. This will allow us not only to have enough vaccines to comply with the vaccination plans, but also to be able to comply for Latin America , which is also the goal of VaxThera,” said Lina Bustamente, Secretary of Health of Antioquia.

MELISSA ALVAREZ CORREA
TIME CORRESPONDENT

The United States will soon ship more than 2 million doses of the Pfizer COVID-19 vaccine to the African nations of Kenya and Morocco, the White House told VOA on Wednesday.

“As the president has said, America will be the arsenal of vaccines in our fight against COVID-19,” a White House official told VOA. “We are proud to be able to deliver these safe and effective vaccines to the people of Kenya and Morocco.”

Those donations bring the U.S. to a milestone, said White House press secretary Jen Psaki.

“Today, we hit a major milestone in our global effort to be the arsenal of vaccines: 400 million doses shipped to 112 countries for free, with no strings attached,” Psaki said Wednesday. “To put America’s leadership into perspective, we have shipped four times more free doses to the world than any other country. And this is on top of our efforts to expand manufacturing at home and abroad, our close partnerships with manufacturers to provide their vaccines to hard-hit areas, and our work to turn vaccines into vaccinations around the globe.”

In the latest round of donations, Kenya will receive 517,140 doses of the two-dose Pfizer vaccine. Morocco will get 1,599,390 doses. The donations will be distributed by COVAX, a global initiative founded to ensure equitable access to COVID-19 vaccines. In both countries, the White House told VOA, scientific, legal and regulatory teams are coordinating to ensure the prompt delivery of safe and effective tranches of vaccine. These new doses come from the half-billion doses secured by President Joe Biden’s administration over the summer, the White House said.

Health advocates welcomed the donations but questioned whether they were enough — especially considering that the U.S. is promoting booster doses for already-vaccinated Americans while so many people worldwide have yet to get a first shot.

“Less than 10% of the people in Africa have received a vaccine, and more than 3 billion people (including doctors and nurses) around the world have not received their first dose, even as rich countries are starting to administer fourth doses,” said Robbie Silverman, senior manager of private sector advocacy at Oxfam America, a Boston-based organization that advocates for the poor.

“Table scraps from rich countries — who have hoarded the vast majority of the world’s mRNA vaccine doses — will not end the pandemic and will not stop the emergence of new variants that could threaten the United States,” Silverman said. “The U.S. should lead in responding to what low- and middle-income countries are actually asking for — the ability to manufacture their own doses for their own citizens. This starts with opening the vaccine recipe, sharing the technical know-how and providing resourcing to qualified manufacturers throughout the world.”

Kenya, an East African coastal nation of nearly 54 million people, has reported more than 320,000 confirmed cases and 5,558 deaths from the virus, according to World Health Organization data. As of this week, nearly 11.3 million vaccine doses have been administered, WHO says. Kenya appears to have endured at least five waves of infection. Compared with the previous four waves, the last wave, which peaked in December and has since fallen sharply, resulted in the greatest number of known infections but the lowest number of deaths.

Morocco, a North African nation of nearly 37 million people, has seen more than 1,100,000 confirmed cases and 15,167 deaths, according to the WHO. Nearly 51.9 million vaccines have been administered. WHO data appear to show that Morocco is in the midst — possibly the peak — of a third wave.

Thousands of anti-mask and vaccine mandate protesters rallied on the mall in Washington, D.C., on Sunday to voice opposition to the Biden administration’s COVID-19 mask and vaccine policies.

Gathering at the base of the Washington Monument, and then marching to the Lincoln Memorial, the protesters held signs saying, “Make Love Not Mandates!!” and “Coercion is Not Choice.”

COVID-19 has killed more than 860,000 people in the United States – and more than 5.5 million globally — over the two-year-long pandemic and has weighed heavily on the economy.

On January 13, the U.S. Supreme Court blocked President Joe Biden’s COVID-19 vaccination-or-testing mandate for large businesses — a policy the conservative justices deemed an improper imposition on the lives and health of many Americans — while endorsing a separate federal vaccine requirement for health care facilities.

Many U.S. companies have implemented mandatory mask-wearing policies to protect their workers, as have various municipalities and cultural organizations.

Masks remain polarizing. Biden, a Democrat, recently urged people to wear masks and noted that about a third of Americans report they do not wear masks at all. Many Republican-leaning states have no mask requirements. Some Democratic-governed states such as California have reimposed indoor mask mandates.

The third dose of the vaccine against covid neutralizes the omicron variant, according to the ENECovid study, presented by the director of the Carlos III Health Institute, Cristóbal Belda

The third dose of the covid vaccine neutralizes the omicron variant

Araceli, a 96-year-old woman, resident at the Los Olmos center for the elderly in Guadalajara, the first to be vaccinated in Spain against the coronavirus on December 27, 2020/EFE/Pepe Zamora POOL

The third dose of the covid vaccine neutralizes the omicron variant

Belda presented the first results of this study by the Carlos III Institute, at a press conference, at the Palacio de la Moncloa, together with the Minister of Health, Carolina Darias, after the meeting of the Interterritorial Health Council.

“Clearly there are new antibodies after the third dose, both in people who have had the covid infection and those who have not”, according to research carried out in a study with 1,200 people over 65 years of age who have received this reinforcement of the vaccination schedule, Belda said.

“And these antibodies – he continued – are ten times more effective against omicron than in people who do not receive the third dose. Cellular immunity remains stable with the third dose.”

“The antibodies work, in the delta variant 17 times more, and in omicron, 10”, added the director of the Carlos III Health Institute.

Cristóbal Belda has concluded: “The third dose neutralizes the omicron variant. These are first results and more will come, but the efficacy of the third dose is relevant compared to ómicron».

Evolution of vaccination

The minister has recalled the basic data on the evolution of vaccination against covid.

The number of people over 12 years of age with a complete immunization schedule is 90.6 percent.

People over 60 years of age who have already received the third dose are 88.9 percent.

The children between 5 and 11 years who have received the first dose are 46 percent.

“Must continue reinforcing vaccination at all ages”, said Darias, who recalled that since last week those over 18 years of age can inject the third dose against SARS-CoV-2, and has called for the acceleration of vaccination, especially between 40 and 59 years old.

“Vaccines save lives; They protect us against serious illness from the virus, hospitalization, admission to the ICU and death,” he added.

Between 60 and 79 years of age, in vaccinated people there are six times fewer hospitalizations, 29 times fewer admissions to intensive care units and 20 times fewer deaths from covid, the minister has completed.

cancer research
The director of the Carlos III Health Institute, Cristóbal Belda. EFE/
top